Kurma Partners has closed its fourth biotech venture capital fund after raising 215 million euros ($252 million) to support ...

A major biotech company is leaving the Bay Area. Pfizer is abandoning its research site at 181 Oyster Point Blvd. in South San Francisco. The biotech company will move out of the building by the end ...

Anthropic has purchased the stealth biotech AI startup Coefficient Bio in a $400 million stock deal, according to The Information and Eric Newcomer. Sources close to the deal confirmed to TechCrunch ...

Biotech has benefited marginally from this rotation. Value beat growth notably in the first quarter. The energy sector was obviously the best performing of the 11 sectors of the S&P 500 in Q1 with a ...

Have we passed the peak of biotech layoffs? It’s too early to say for certain—but an intriguing story is playing out in the figures. According to an analysis of Fierce Biotech’s layoff data, a total ...

Adam Feuerstein, a senior writer and biotech columnist, is the author of Adam’s Biotech Scorecard, a subscriber-only newsletter about the crossroads of drug development, business, Wall Street, and ...

Half a year after being spurned by the FDA and following deep layoffs, IO Biotech has decided to close its doors for good. The Danish biotech has ceased operations and said goodbye to its employees, C ...

U.S. venture capital firms are no longer waiting for Chinese biotech assets to surface before investing in them — they’re moving upstream, embedding themselves inside labs and courting scientists ...

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. In 2025, biotechnology stocks had their best year since the COVID-19 ...

Honking horns and screeching tires used to be a cliched scene-setting device for writers describing Paris. Those sounds no longer define a city where cars have taken a back seat. Visitors will ...

Journal Editorial Report: The week's best and worst from Kate Odell, Kyle Peterson and Dan Henninger. Photo: Ben Curtis/Allison Robbert/AP/Stefani Reynolds/CNP via ZUMA Wire Indian manufacturers ...

As pharmas like Eli Lilly and Roche bolster their biotech offerings, Pfizer is snuffing out its program designed to incubate new innovations from select companies, dubbed Pfizer Ignite. The Ignite ...